K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research

COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that might lead to very serious consequences. Notably, mental status change, brain confusion, and smell and taste disorders along with neurological complaints have been reported in patients infecte...

Full description

Bibliographic Details
Main Authors: Simona Dedoni, Valeria Avdoshina, Chiara Camoglio, Carlotta Siddi, Walter Fratta, Maria Scherma, Paola Fadda
Format: Article
Language:English
Published: MDPI AG 2022-06-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/27/13/4142
_version_ 1797408595438993408
author Simona Dedoni
Valeria Avdoshina
Chiara Camoglio
Carlotta Siddi
Walter Fratta
Maria Scherma
Paola Fadda
author_facet Simona Dedoni
Valeria Avdoshina
Chiara Camoglio
Carlotta Siddi
Walter Fratta
Maria Scherma
Paola Fadda
author_sort Simona Dedoni
collection DOAJ
description COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that might lead to very serious consequences. Notably, mental status change, brain confusion, and smell and taste disorders along with neurological complaints have been reported in patients infected with SARS-CoV-2. Furthermore, human brain tissue autopsies from COVID-19 patients show the presence of SARS-CoV-2 neuroinvasion, which correlates with the manifestation of meningitis, encephalitis, leukocyte infiltration, and neuronal damage. The olfactory mucosa has been suggested as a way of entry into the brain. SARS-CoV-2 infection is also known to provoke a hyper-inflammatory reaction with an exponential increase in the production of pro-inflammatory cytokines leading to systemic responses, even in the absence of direct infection of brain cells. Angiotensin-converting enzyme 2 (ACE2), the entry receptor of SARS-CoV-2, has been extensively demonstrated to be present in the periphery, neurons, and glial cells in different brain regions. To dissect the details of neurological complications and develop therapies helping COVID-19 survivors regain pre-infection quality of life, the development of robust clinical models is highly warranted. Several human angiotensin-converting enzyme 2 (hACE2) transgenic mouse models have been developed and used for antiviral drug screening and vaccine development, as well as for better understanding of the molecular pathogenetic mechanisms of SARS-CoV-2 infection. In this review, we summarize recent results from the studies involving two such mouse models, namely K18- and CAG-hACE2 transgenics, to evaluate the direct and indirect impact of SARS-CoV-2 infection on the central nervous system.
first_indexed 2024-03-09T04:01:44Z
format Article
id doaj.art-add7f108131149b08429059a4631e54e
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-09T04:01:44Z
publishDate 2022-06-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-add7f108131149b08429059a4631e54e2023-12-03T14:13:30ZengMDPI AGMolecules1420-30492022-06-012713414210.3390/molecules27134142K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration ResearchSimona Dedoni0Valeria Avdoshina1Chiara Camoglio2Carlotta Siddi3Walter Fratta4Maria Scherma5Paola Fadda6Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Neuroscience, Georgetown University Medical Center, Washington, DC 20057, USADepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyDepartment of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Sardinia, ItalyCOVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that might lead to very serious consequences. Notably, mental status change, brain confusion, and smell and taste disorders along with neurological complaints have been reported in patients infected with SARS-CoV-2. Furthermore, human brain tissue autopsies from COVID-19 patients show the presence of SARS-CoV-2 neuroinvasion, which correlates with the manifestation of meningitis, encephalitis, leukocyte infiltration, and neuronal damage. The olfactory mucosa has been suggested as a way of entry into the brain. SARS-CoV-2 infection is also known to provoke a hyper-inflammatory reaction with an exponential increase in the production of pro-inflammatory cytokines leading to systemic responses, even in the absence of direct infection of brain cells. Angiotensin-converting enzyme 2 (ACE2), the entry receptor of SARS-CoV-2, has been extensively demonstrated to be present in the periphery, neurons, and glial cells in different brain regions. To dissect the details of neurological complications and develop therapies helping COVID-19 survivors regain pre-infection quality of life, the development of robust clinical models is highly warranted. Several human angiotensin-converting enzyme 2 (hACE2) transgenic mouse models have been developed and used for antiviral drug screening and vaccine development, as well as for better understanding of the molecular pathogenetic mechanisms of SARS-CoV-2 infection. In this review, we summarize recent results from the studies involving two such mouse models, namely K18- and CAG-hACE2 transgenics, to evaluate the direct and indirect impact of SARS-CoV-2 infection on the central nervous system.https://www.mdpi.com/1420-3049/27/13/4142COVID-19K18-transgenic miceCAG-hACE2 transgenic miceneuroinvasioninflammation
spellingShingle Simona Dedoni
Valeria Avdoshina
Chiara Camoglio
Carlotta Siddi
Walter Fratta
Maria Scherma
Paola Fadda
K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
Molecules
COVID-19
K18-transgenic mice
CAG-hACE2 transgenic mice
neuroinvasion
inflammation
title K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
title_full K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
title_fullStr K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
title_full_unstemmed K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
title_short K18- and CAG-hACE2 Transgenic Mouse Models and SARS-CoV-2: Implications for Neurodegeneration Research
title_sort k18 and cag hace2 transgenic mouse models and sars cov 2 implications for neurodegeneration research
topic COVID-19
K18-transgenic mice
CAG-hACE2 transgenic mice
neuroinvasion
inflammation
url https://www.mdpi.com/1420-3049/27/13/4142
work_keys_str_mv AT simonadedoni k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch
AT valeriaavdoshina k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch
AT chiaracamoglio k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch
AT carlottasiddi k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch
AT walterfratta k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch
AT mariascherma k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch
AT paolafadda k18andcaghace2transgenicmousemodelsandsarscov2implicationsforneurodegenerationresearch